Ron Cooper, enGene CEO
September 26, 2024 07:00 AM EDT
R&D
Cell/Gene Tx

En­Gene un­veils first set of piv­otal da­ta for NMIBC ther­a­py

Kyle LaHucik

Senior Reporter

A small US and Cana­di­an gene ther­a­py biotech has re­leased a look at da­ta from its ex­per­i­men­tal blad­der can­cer treat­ment, hop­ing to en­ter a field …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times